Dr. Kirstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
264 North Highland Springs Avenue
Banning, CA 92220Phone+1 801-580-2232
Summary
- I retired from family medicine 7/31/13 and am working full time at Advanced Clinical Research (801-542-8190 ext 109). ACR is a stand alone clinical research facility where we do a wide variety of research studies on chronic conditions, such as gout, HTN, DM, as well as new vaccines, such as Dengue fever, smallpox, botulism, rabies.
I also do acupuncture part time at the ACR office (3590 West 9000 South, Suite 300, West Jordan). Patients are welcome to call the number listed above for appointment. I do not do acu for weight loss.
Education & Training
University of Utah HealthResidency, Family Medicine, 1978 - 1981
David Geffen School of Medicine at UCLAClass of 1978
Certifications & Licensure
CA State Medical License 2018 - 2026
UT State Medical License 1979 - 2022- American Board of Family Medicine Family Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia Start of enrollment: 2009 Jun 01
- The Plecanatide Chronic Idiopathic Constipation (CIC) Study Start of enrollment: 2011 Oct 01
- Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC) Start of enrollment: 2013 Aug 01
Press Mentions
Moderna Phase 3 Trial Data Shows 94 Percent Efficacy Against COVID-19December 4th, 2020
Une Nouvelle Étude De Phase III Montre Une Efficacité Significativement plus Grande Chez Les Enfants De 6 Mois À 24 Mois Qui Reçoivent Un Vaccin Avec Adjuvant Contre La Grippe (aQIV)September 12th, 2017- New Phase III Study Shows Significantly Greater Efficacy in Children 6-24 Months Who Receive Adjuvanted Influenza Vaccine (aQIV)September 11th, 2017
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
